a plasma biomarker signature of immune activation in hiv patients on antiretroviral therapy等离子体生物标志物签名的免疫激活在抗逆转录病毒治疗的艾滋病患者.pdfVIP

a plasma biomarker signature of immune activation in hiv patients on antiretroviral therapy等离子体生物标志物签名的免疫激活在抗逆转录病毒治疗的艾滋病患者.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a plasma biomarker signature of immune activation in hiv patients on antiretroviral therapy等离子体生物标志物签名的免疫激活在抗逆转录病毒治疗的艾滋病患者

A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy 1,2 1 1,2 3 4 4 Anupa Kamat , Vikas Misra , Edana Cassol , Petronela Ancuta , Zhenyu Yan , Cheng Li , Susan Morgello5, Dana Gabuzda1,2* 1 Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, 2 Harvard Medical School, Boston, ´ ´ Massachusetts, United States of America, 3 Department of Microbiology and Immunology, Faculty of Medicine, CHUM-Research Center, Universite de Montreal, Montreal, Canada, 4 Department of Biostatistics, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, 5 Mount Sinai Medical Center, New York, United States of America Abstract Background: Immune activation is a strong predictor of disease progression in HIV infection. Combinatorial plasma biomarker signatures that represent surrogate markers of immune activation in both viremic and aviremic HIV patients on combination antiretroviral therapy (cART) have not been defined. Here, we identify a plasma inflammatory biomarker signature that distinguishes between both viremic and aviremic HIV patients on cART and healthy controls and examine relationships of this signature to markers of disease progression. Methods: Multiplex profiling and ELISA were used to detect 15 cytokines/chemokines, soluble IL-2R (sIL-2R), and soluble CD14 (sCD14) in plasma from 57 HIV patients with CD4 nadir ,300 cells/ml and 29 healthy controls. Supervised

您可能关注的文档

文档评论(0)

qianqiana + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5132241303000003

1亿VIP精品文档

相关文档